Industry Research Reports: Oncology

Showing posts with label Oncology. Show all posts

Sunday, 14 July 2013

Research Report: Global Gastrointestinal Devices Market Analysis 2012-2016

TechNavio's analysts forecast the Global Gastrointestinal (GI) Devices market to grow at a CAGR of 4.76 percent over the period 2012- 2016. One of the key factors contributing to this market growth is the increasing prevalence of GI disorders The Global GI Devices market has also been witnessing an increasing demand for minimally invasive procedures. However, the presence of alternative procedures could pose a challenge to the growth of this market.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/global-gastrointestinal-devices-market-2012-2016

TechNavio's report, the Global GI Devices Market 2012- 2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global GI Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Boston Scientific Corp., Covidien Plc., Ethicon Endo- Surgery Inc., and Olympus Corp.

The other vendors mentioned in the report are Coloplast Group, Fujinon Corp., Given Imaging Ltd., Stryker Corp., and Welch Allyn Inc.

Key questions answered in this report:

What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/171193

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Wednesday, 26 June 2013

Market Overview: Oncology Pipeline Database: 6-Month Subscription Market Trends

Product description

Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Territories, Product Categories and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name.

Purchase of the subscription provides a 6-month online access to the data of the Oncology Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/oncology-pipeline-database-6-month-subscription

Benefits from the Oncology Pipeline Database:

New database with no historical burden
Intuitive use
Designed for structured searches
Focused on targets, product categories and R&D phases
Ideal for competitor analysis (companies, targets, product categories)
Cost-effective and rapid solution for benchmarking
Identification of licensing candidates

Project listing in a tabular format:

Drug Codes
Target / Mechanism of Action
Class of Compound
Product Category
Company
Territory
Therapeutic Area
Indication
R&D Phase

Product Categories:

Antibodies
Cells
DNA
Medical Devicer / Biomaterial
Peptide
Protein
Radiopharmaceutical
RNA
Small Molecule
Vaccine

Predefined Targets of the Scroll Down Menu:

Antibody-Drug Conjugates (ADC)
Aurora Kinase Inhibitors
Bcr-Abl and Src Kinase Inhibitors
c-MET/HGF Inhibitors
CD3 Antagonists
CD19 Antagonists
CD20 Antibodies
CD22 Antibodies
CD30 Antibodies
CD40/L
CEA Antibodies
CHK and KSP/Eg5 Inhibitors
CXCR and CXCL Agonists & Antagonists
Death Receptors TRAIL-R1/2
EGF-R Agonists and Antagonists
EpCAM Antagonists
G-CSF and GM-CSF
HDAC Inhibitors
Heat shock protein 90 (Hsp90) Inhibitors
Hypoxia-Inducible Factor (HIF)
IGF-1R Antagonists
Immunocytokines
Immunotoxins
Integrin Antagonists
Interferon
Janus Kinase (JAK) Inhibitors
MEK Inhibitors
Novel Mitotic Kinase Inhibitors
PARP Inhibitors
PDGF-R Agonists and Antagonists
PI3K-AKT-mTOR Inhibitors
Polo-like Kinase 1 (Plk-1) Inhibitors
Proteasome Inhibitors
Raf Inhibitors
Ras-Raf-MEK-ERK Inhibitors
Selective Estrogen Receptor Modulators (SERM)
TGF-R Agonists and Antagonists
Thrombopoiesis Stimulating Agents (TPO)
Toll-Like Receptor (TLR) Agonists and Antagonists
TRAIL-R1/R2 (Death Receptors)
VEGF and VEGF-R Agonists and Antagonists

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/139849